Taking stock of the drug industry, from the lab to the medicine chestMay 1, 2025Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Jose Luis Magana/AP FDA to rehire fired staffers who booked inspection trips, but other workers remain in limbo The apparent reversals are the latest examples of the haphazard approach to agency cuts that have shrunk FDA's workforce by an estimated 20%. By Associated Press STAT+ | Eli Lilly shares fall as competitor Novo notches coverage win for obesity drug Novo reached a coverage deal with CVS Caremark, giving its obesity drug Wegovy a boost as it competes against Lilly's Zepbound By Elaine Chen STAT+ | Lawmakers, health groups call on RFK Jr. to restore public comment on HHS business Democratic lawmakers in Congress are pushing back on the health secretary's decision to suspend public comment on much of HHS' business. By Isabella Cueto More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments